NCT02182713View on ClinicalTrials.gov

Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

September 30, 1998

Conditions
Asthma
Interventions
DRUG

Salbutamol sulfate/Ipratropium bromide

Salbutamol sulfate 120 mcg + Ipratropium bromide 20 mcg per puff

DRUG

Salbutamol

Salbutamol 100 mcg per puff

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY